Abstract
Quality of single optical coherence tomography angiography (OCTA) images of myopic choroidal neovascularisation (mCNV) is poorer than in averaged images, although obtaining averaged images takes much time. This study evaluated the clinical usefulness of novel denoising process for depicting mCNV. This study included 20 eyes of 20 patients with mCNV. Ten en face images taken in a 3 × 3 mm macular cube were obtained from outer-retina-to-choriocapillaris layer. Three image types were prepared for analysis; single images before and after the denoising process accomplished deep learning (single and denoising groups, respectively) and up to 10 images were averaged (averaging group). Pairwise comparisons showed vessel density, vessel length density, and fractal dimension (FD) were higher; whereas, vessel density index (VDI) was lower in single group than in denoising and averaging groups. Detectable CNV indices, contrast-to-nose ratio, and CNV diagnostic scores were higher in denoising and averaging groups than in single group. No significant differences were detected in VDI, FD, or CNV diagnostic scores between denoising and averaging groups. The denoising process can utilise single OCTA images to provide results comparable to averaged OCTA images, which is clinically useful for shortening examination times with quality similar to averaging.
Subject terms: Medical research, Structural biology
Introduction
Myopic choroidal neovascularisation (mCNV) is one of the commonest vision-threatening complications in highly myopic eyes1. Early mCNV treatment with an intravitreal anti-vascular endothelial growth factor (anti-VEGF) agent is safe and effective2–4. Anti-VEGF therapy has become the standard-of-care and recommended first-line treatment option for mCNV5. Therefore, early detection of mCNV has become essential to prevent mCNV complications.
Optical coherence tomography angiography (OCTA) is a novel, noninvasive modality that facilitates depth-resolved visualisation of retinal and choroidal blood flow without a dye injection, which may induce general complications6. A previous study reported the usefulness of OCTA in detecting mCNV7. Furthermore, OCTA-derived parameters of vessel length density (VLD) and fractal dimension (FD) can be predictors of poor visual outcomes after anti-VEGF therapy in mCNV8. Recently, some reports showed that averaging multiple en face OCTA images improves image quality9–12. However, it takes longer to obtain many OCTA images for averaging than to take a single OCTA image. A novel OCTA device with denoising process function accomplished by deep learning that has been used for clinical practice13 can clearly visualise OCTA images. However, the reliability of denoised OCTA images has not been shown in mCNV.
This study compares single OCTA mCNV images from before and after the denoising process and results of averaging multiple images to assess whether the denoising process was clinically useful for depicting mCNV.
Methods
This prospective, observational, case-series study was approved by the ethics committee of the Kyoto University Graduate School of Medicine (Kyoto, Japan). All study protocols adhered to the tenets of the Declaration of Helsinki and its later amendments. The nature of the study and possible risks and benefits of participation were explained to all study candidates. All individuals who agreed to participate provided written informed consent.
Participants
This study included consecutive patients with highly myopic eyes (defined by a spherical equivalent ≤ −6.00 dioptres and/or an axial length (AL) ≥ 26 mm) with mCNV, who visited the Department of Ophthalmology and Visual Sciences at Kyoto University Graduate School of Medicine (Kyoto, Japan) between November 2017 and September 2019. All patients underwent a comprehensive ophthalmologic examination including autorefractometry, measurement of best-corrected visual acuity with a decimal visual acuity chart (Landolt chart), AL measurement by partial coherence interferometry (IOLMaster, Carl Zeiss Meditec, Inc, Dublin, CA), indirect ophthalmoscopy, slit-lamp biomicroscopy, colour fundus photography (TRC-NW8F; Topcon Corp, Tokyo, Japan), spectral domain optical coherence tomography (SD-OCT; Spectralis HRA + OCT; Heidelberg Engineering, Heidelberg, Germany), fundus fluorescein angiography (FA), fundus indocyanine green angiography (ICGA; HRA II; Heidelberg Engineering), and OCTA (OCT-HS100; Canon Lifecare Solutions, Inc, Tokyo, Japan) with a maximum 10 images being averaged; this image maximum is more than the images averaged (5 images) in a previous study12. Retinal specialists diagnosed mCNV using SD-OCT, FA, and ICGA data. The inclusion criteria were a clinical diagnosis of mCNV and mCNV presence determined using averaged OCTA images by a retinal specialist (MM). The exclusion criteria were OCTA images of poor quality that hindered image analysis including significant segmentation errors and motion artefacts and the presence of other eye diseases including epiretinal membrane and vitreomacular traction syndrome. When both eyes of a patient were eligible, the right eye was selected for analysis.
Quantitative assessment of OCTA images
All OCTA images were acquired using the macular cube (3 × 3 mm) protocol of the OCT-HS 100 scanner containing 232 × 232 A-scans. The built-in software automatically performed layer segmentation; the en face image of outer-retina-to-choriocapillaris (ORCC) layer was obtained with the inner and outer boundaries at the outer border of the outer plexiform layer and 8 μm beneath the Bruch’s membrane, respectively, as previously reported14. Three types of OCTA images were prepared for analysis in each participant (Fig. 1): (1) the first single image before the built-in denoising process was accomplished by deep learning with image augmentation (detailed information is undisclosed) undertaken with the built-in software of OCT-HS100 (single group), (2) the first single image after the denoising process (denoising group), and (3) averaged images from a maximum of 10 images (averaging group). When the first single image quality was poor, the second or third single image was selected.
In OCTA en face images of the ORCC layer, the parameters of vessel density (VD), VLD, vessel diameter index (VDI), and FD that represent the CNV status were measured for images from individuals in the 3 groups using open-source software (ImageJ, National Institutes of Health, Bethesda, MD) in accordance with a previous report8. Briefly, once the CNV lesion was manually cropped, the VD was defined as the ratio (%) of the area occupied by vessels after binarisation by local thresholding with the Otsu method. The VLD value was defined as the ratio (%) of the area occupied by skeletonised vessels after skeletonisation (Fig. 2)9,15,16. The VDI value was calculated using the following formula:
where VDI represents the average vessel calibre. FD was calculated by measuring the degree of pattern complexity by the box-counting method that determines vessel complexity, as described previously15,17. The absolute value of VDI required Littmann’ correction18. These OCTA-derived parameters would demonstrate the visible vascularity of CNV.
Detectability indices of choroidal neovascularisation
To evaluate CNV detectability indexes, we assessed the contrast-to-noise ratio (CNR) and CNV diagnostic scores for images of three groups. Although the foveal avascular zone is generally used as the background in CNR analyses for vascular flow in the superficial and deep capillary plexus layers11, avascular sites such as the foveal avascular zone are absent in the ORCC layer. Therefore, the darkest area around the CNV area was designated as the background and the whole CNV area was defined as the foreground (Fig. 3). The same background and foreground sites were selected in 3 individual images. Mean grey values and their standard deviations were analysed using ImageJ and the CNR was calculated as follows:
where f and b are the mean grey values of the foreground and background, respectively, and δf and δb are their standard deviations, respectively. When the CNR is high, the CNV area has a higher contrast than that of the area around it; thus, a CNV area with a high CNR is thought to be more detectable than a CNV area with a low CNR.
Two blinded retinal specialists (YK and SK) individually and subjectively randomly assessed CNV presence without information whether mCNV was present. The subjective assessments consisted of CNV diagnostic scores that were categorised as follows: 0 = no CNV, 1 = CNV suspicion, and 2 = CNV presence. When the investigator (MM) found that each score differed considerably between the 2 investigators, a reassessment was conducted until the difference of scores fell within 1. Thus, the mean scores from 2 investigators were used for analysis. Taken together, the CNV diagnostic scores imply total subjective judgement of CNV presence from factors including visible vascularity of CNV (OCTA-derived parameters) and differences between CNV and its surroundings (CNR).
Sub-analysis of measurement time
The time that a healthy person fixes his/her face on the OCTA device during a single scan and 10 scans for 1 eye as well as the time required for the denoising process and averaging after scanning were measured.
Statistical analysis
Data are presented as the mean ± the standard deviation where applicable. All statistical analyses were undertaken in using SPSS (version 21; IBM, Armonk, NY). Statistical comparisons among the 3 groups were conducted using an analysis of variance with repeated measures; subsequent pairwise comparisons were undertaken with a Bonferroni test. P-values < 0.05 were considered statistically significant.
Results
Twenty eyes of 20 patients met the inclusion criteria (15 women; 66.9 ± 12.4 years). The AL and refractive errors of all patients were 28.41 ± 1.27 mm and −6.66 ± 4.67 dioptres, respectively. Nine patients (45%) had undergone intraocular lens implantation after cataract surgery, although the remainder of patients had not. There were significant differences in VD, VLD, VDI, FD, CNR, and CNV diagnostic scores among the 3 groups (Table 1). Pairwise comparisons in OCTA-derived parameters show that VD, VLD, and FD were higher in the single group than in the denoising and averaging groups. The VDI was lower in the single group than in the denoising and averaging groups. With regard to CNV detectability indices, CNR and CNV diagnostic scores were higher in the denoising and averaging groups than in the single group. There were no significant differences in VDI, FD, or CNV diagnostic scores between the denoising and averaging groups. Data for these comparisons are described in Table 1.
Table 1.
Single group (G1) | Denoising group (G2) | Averaging group (G3) | P-values among the 3 groups | P-value of pairwise comparisons | |||
---|---|---|---|---|---|---|---|
G1 vs G2 | G1 vs G3 | G2 vs G3 | |||||
VD, % | 33.4 ± 8.3 | 29.7 ± 9.3 | 26.0 ± 12.1 | <0.001* | <0.001* | <0.001* | 0.004* |
VLD, % | 11.9 ± 2.9 | 9.0 ± 3.0 | 7.7 ± 3.8 | <0.001* | <0.001* | <0.001* | 0.03* |
VDI | 31.7 ± 5.1 | 37.6 ± 6.7 | 40.2 ± 9.9 | 0.001* | <0.001* | 0.002* | 0.66 |
FD | 1.5 ± 0.1 | 1.4 ± 0.1 | 1.3 ± 0.3 | <0.001* | <0.001* | 0.004* | 0.61 |
CNR | 1.2 ± 0.3 | 1.7 ± 0.4 | 1.5 ± 0.3 | <0.001* | <0.001* | <0.001* | 0.03* |
CNV diagnostic scores | 0.8 ± 0.6 | 1.3 ± 0.6 | 1.6 ± 0.4 | <0.001* | 0.008* | <0.001* | 0.12 |
Data are presented as the mean ± the standard deviation.
VD = vessel density; VLD = vessel length density; VDI = vessel diameter index; FD = fractal dimension; CNR = contrast-to-noise ratio; CNV = choroidal neovascularization.
Statistical comparisons were conducted among the three groups using an analysis of variance with repeated measures; subsequent pairwise comparisons were conducted with a Bonferroni test.
*Statistically significant P < 0.05.
The time that a 28-year-old healthy female individual fixed her face on the OCTA device at a single scan for 1 eye was approximately 5 seconds and the time for 10 scans was approximately 248 seconds, although the time would vary in accordance with individual patient status. The actual time of the denoising and averaging processes after scanning was 5 and 24 seconds, respectively.
Discussion
The present findings demonstrate that the built-in denoising process accomplished by deep learning improved the quality of single OCTA images of mCNV in all OCTA-derived parameters and CNV detectability indices in this study; furthermore, single denoised OCTA images could be used in lieu of averaged images. As it takes longer to obtain OCTA images via the averaging process than to obtain single images, the denoising process can decrease the burden on patients and examiners as it only requires 1 image.
In the present study, denoising accomplished by deep learning lowered VD, VDI, and FD, but increased VLD in mCNV; these trends are similar with the averaging results. Moreover, on OCTA images of mCNV, CNV vessels became sharp and had low pattern complexity after the denoising and averaging processes. As a result, the denoising and averaging processes presented CNV vessels as distinct from normal vessels. Thus, the denoising process is useful for detecting mCNV using a single OCTA image.
Biomicroscopic features of mCNV include a light-coloured lesion with a dark and hyperpigmented rim19. Therefore, the CNV detectability index included CNR in the present study with the CNV area as the foreground and the darkest sites around the CNV area as the background. The CNR values were higher in the denoising group than in the single and averaging groups. The OCTA images of mCNV after the denoising process had a high contrast between the CNV area and the dark rim around the CNV area. Furthermore, CNV diagnostic scores were higher in the denoising group than in the single group; there were no significant differences between the denoising and averaging groups. Thus, in clinical practice for mCNV detection, a denoising process is useful in a manner similar to that of averaging.
Artificial intelligence with deep learning technology has recently played an important role in diagnosis and treatment, health management, drug research and development, and precision medicine13. In ophthalmology, some researchers report that deep learning can support an automatic diagnosis of glaucomatous optic neuropathy, diabetic retinopathy, and central serous chorioretinopathy20–22. Furthermore, nonperfused areas could be automatically detected using deep learning23. In the present study, mCNV on single OCTA images could be depicted more clearly using an automatic denoising process that was accomplished by deep learning than by single OCTA images before the denoising process. In the future, deep learning technology will likely spread to various operations in ophthalmology.
The present study has some limitations. First, the sample size was small. Eleven eyes of 11 patients with averaged OCTA images of poor quality could not be analysed and were excluded. Improvements to OCTA devices are necessary in parallel with improvements in deep learning technology. Second, the cropping procedure of the CNV area using ImageJ was manually executed. However, because the CNV border is often clear in mCNV, a previous report also used a manual cropping procedure8. Third, the background for the CNR assessment was manually selected; we could not automatically select the whole area while excluding the CNV area. However, due to the mean grey value of the background included in normal vessels, the value was inadequate to distinguish the dark rim around the mCNV region19. To avoid bias, the same sites were selected in all 3 groups in each participant. Fourth, since denoised mCNV OCTA images are altered (not original), the possibility that the images might not appear to be true CNV images was a concern. However, the denoising process did not produce any unexpected images. Fifth, 2 investigators did not assess CNV diagnostic scores of OCTA images without mCNV. Thus, there may have been a bias in the CNV diagnostic scores.
In conclusion, a novel built-in denoising process accomplished by deep learning can create single OCTA images similar to that of averaged OCTA images. This process is clinically useful to shorten examination times whereas providing results of similar quality as obtained with averaging.
Acknowledgements
This work was supported in part by a grant-in-aid for scientific research (no. 18K09444) from the Japan Society for the Promotion of Science, Tokyo, Japan. This organisation had no role in the design or conduct of this research.
Author contributions
Y.S. and M. Miyata. wrote the main manuscript text; Y.S., M. Miyata, A.U., S.O., H.T., N.U., Y.M., M. Miyake, A. Takahashi, Y.K., S.K., Y.O., K.K., K.Y. and A. Tsujikawa analysed data; Y.S. and M. Miyata prepared the figures; M. Miyata and A.U. conceptualised and designed the study; and Y.S., M. Miyata, A.U., S.O., H.T., N.U., Y.M., M. Miyake, A. Takahashi, Y.K., S.K., Y.O., K.K., K.Y. and A. Tsujikawa edited and reviewed the manuscript. All authors have accepted the final version of the manuscript.
Data availability
All data generated or analysed during this study are included in this published article.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology. 1983;90:923–926. doi: 10.1016/S0161-6420(83)80018-9. [DOI] [PubMed] [Google Scholar]
- 2.Lai TY, Luk FO, Lee GK, Lam DS. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization. Eye (Lond). 2012;26:1004–1011. doi: 10.1038/eye.2012.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sarao V, Veritti D, Macor S, Lanzetta P. Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes. Graefes Arch. Clin. Exp. Ophthalmol. 2016;254:445–454. doi: 10.1007/s00417-015-3076-1. [DOI] [PubMed] [Google Scholar]
- 4.Chhablani J, et al. Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group. Br. J. Ophthalmol. 2018;102:455–459. doi: 10.1136/bjophthalmol-2017-310411. [DOI] [PubMed] [Google Scholar]
- 5.Ohno-Matsui K, Ikuno Y, Lai TYY, Gemmy Cheung CM. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog. Retin. Eye Res. 2018;63:92–106. doi: 10.1016/j.preteyeres.2017.10.005. [DOI] [PubMed] [Google Scholar]
- 6.Yannuzzi LA, et al. Fluorescein angiography complication survey. Ophthalmology. 1986;93:611–617. doi: 10.1016/S0161-6420(86)33697-2. [DOI] [PubMed] [Google Scholar]
- 7.Miyata M, et al. Detection of myopic choroidal neovascularization using optical coherence tomography angiography. Am. J. Ophthalmol. 2016;165:108–114. doi: 10.1016/j.ajo.2016.03.009. [DOI] [PubMed] [Google Scholar]
- 8.Hosoda Y, et al. Novel predictors of visual outcome in anti-VEGF therapy for myopic choroidal neovascularization derived using OCT angiography. Ophthalmol. Retina. 2018;2:1118–1124. doi: 10.1016/j.oret.2018.04.011. [DOI] [PubMed] [Google Scholar]
- 9.Uji A, et al. Impact of multiple en face image averaging on quantitative assessment from optical coherence tomography angiography images. Ophthalmology. 2017;124:944–952. doi: 10.1016/j.ophtha.2017.02.006. [DOI] [PubMed] [Google Scholar]
- 10.Uji A, et al. Choriocapillaris imaging using multiple en face optical coherence tomography angiography image averaging. JAMA Ophthalmol. 2017;135:1197–1204. doi: 10.1001/jamaophthalmol.2017.3904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Uji A, et al. Multiple enface image averaging for enhanced optical coherence tomography angiography imaging. Acta Ophthalmol. 2018;96:e820–e827. doi: 10.1111/aos.13740. [DOI] [PubMed] [Google Scholar]
- 12.Murakawa S, Maruko I, Kawano T, Hasegawa T, Iida T. Choroidal neovascularization imaging using multiple en face optical coherence tomography angiography image averaging. Graefes Arch. Clin. Exp. Ophthalmol. 2019;257:1119–1125. doi: 10.1007/s00417-019-04275-5. [DOI] [PubMed] [Google Scholar]
- 13.Xu J, Xue K, Zhang K. Current status and future trends of clinical diagnoses via image-based deep learning. Theranostics. 2019;9:7556–7565. doi: 10.7150/thno.38065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Roisman L, et al. Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology. 2016;123:1309–1319. doi: 10.1016/j.ophtha.2016.01.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Reif R, et al. Quantifying optical microangiography images obtained from a spectral domain optical coherence tomography system. Int. J. Biomed. Imaging. 2012;2012:509783. doi: 10.1155/2012/509783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kim AY, et al. Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 2016;57:362–370. doi: 10.1167/iovs.15-18904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Landini G, Murray PI, Misson GP. Local connected fractal dimensions and lacunarity analyses of 60 degrees fluorescein angiograms. Invest. Ophthalmol. Vis. Sci. 1995;36:2749–2755. [PubMed] [Google Scholar]
- 18.Littmann H. Determination of the true size of an object on the fundus of the living eye. By H. Littmann from the original article, “Zur Bestimmung der wahren Grosse eines Objektes auf dem Hintergrund des lebenden Auges”, which originally appeared in Klinisches Monatsblätter für Augenheilkunde 1982; 180:286–9. Translated by TD Williams. Optom. Vis. Sci. 1992;69:717–720. doi: 10.1097/00006324-199209000-00009. [DOI] [PubMed] [Google Scholar]
- 19.Cheung CMG, et al. Myopic choroidal neovascularization: review, guidance, and consensus statement on management. Ophthalmology. 2017;124:1690–1711. doi: 10.1016/j.ophtha.2017.04.028. [DOI] [PubMed] [Google Scholar]
- 20.Liu, H. et al. Development and Validation of a Deep Learning System to Detect Glaucomatous Optic Neuropathy Using Fundus Photographs. JAMA Ophthalmol, 10.1001/jamaophthalmol.2019.3501. (2019). [DOI] [PMC free article] [PubMed]
- 21.Nielsen KB, Lautrup ML, Andersen JKH, Savarimuthu TR, Grauslund J. Deep learning-based algorithms in screening of diabetic retinopathy: a systematic review of diagnostic performance. Ophthalmol. Retina. 2019;3:294–304. doi: 10.1016/j.oret.2018.10.014. [DOI] [PubMed] [Google Scholar]
- 22.Zhen, Y. et al. Assessment of central serous chorioretinopathy depicted on color fundus photographs using deep learning Retina. 10.1097/IAE.0000000000002621. (2019). [DOI] [PubMed]
- 23.Nagasato D, et al. Automated detection of a nonperfusion area caused by retinal vein occlusion in optical coherence tomography angiography images using deep learning. PLoS ONE. 2019;14:e0223965. doi: 10.1371/journal.pone.0223965. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analysed during this study are included in this published article.